Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis

Recent evidence suggests that the primary progressive form of multiple sclerosis (PP-MS) may present with specific immunological alterations. In this study we focused our attention on CD161, an NK and T cell marker upregulated in relapsing-remitting MS, and investigated its transcript and protein le...

Full description

Bibliographic Details
Main Authors: Massimo Acquaviva, Claudia Bassani, Nicole Sarno, Gloria Dalla Costa, Marzia Romeo, Francesca Sangalli, Bruno Colombo, Lucia Moiola, Vittorio Martinelli, Giancarlo Comi, Cinthia Farina
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.01922/full
_version_ 1831683841762263040
author Massimo Acquaviva
Claudia Bassani
Nicole Sarno
Gloria Dalla Costa
Marzia Romeo
Francesca Sangalli
Bruno Colombo
Lucia Moiola
Vittorio Martinelli
Giancarlo Comi
Cinthia Farina
author_facet Massimo Acquaviva
Claudia Bassani
Nicole Sarno
Gloria Dalla Costa
Marzia Romeo
Francesca Sangalli
Bruno Colombo
Lucia Moiola
Vittorio Martinelli
Giancarlo Comi
Cinthia Farina
author_sort Massimo Acquaviva
collection DOAJ
description Recent evidence suggests that the primary progressive form of multiple sclerosis (PP-MS) may present with specific immunological alterations. In this study we focused our attention on CD161, an NK and T cell marker upregulated in relapsing-remitting MS, and investigated its transcript and protein levels in blood cells from PP-MS and healthy individuals. We demonstrated transcriptional downregulation of CD161 in PP-MS and described concomitant mRNA reduction for RORgt, CCR6, CXCR6, KLRK1/NKG2D and many other markers typical of mucosa associated invariant T (MAIT) cells. Targeted multiparametric flow cytometry on fresh blood cells from an independent cohort of case-control subjects confirmed the selective loss of circulating CD8 CD161high T cells, which consist mainly of MAIT cells, and not of CD8 CD161int T cells in PP-MS. These data demonstrate alterations in a specific circulating immune cell subset in MS patients with progressive onset.
first_indexed 2024-12-20T06:45:25Z
format Article
id doaj.art-c7ef3bad3bf346a4b87d2660178b8c49
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T06:45:25Z
publishDate 2019-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c7ef3bad3bf346a4b87d2660178b8c492022-12-21T19:49:44ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-08-011010.3389/fimmu.2019.01922451680Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple SclerosisMassimo AcquavivaClaudia BassaniNicole SarnoGloria Dalla CostaMarzia RomeoFrancesca SangalliBruno ColomboLucia MoiolaVittorio MartinelliGiancarlo ComiCinthia FarinaRecent evidence suggests that the primary progressive form of multiple sclerosis (PP-MS) may present with specific immunological alterations. In this study we focused our attention on CD161, an NK and T cell marker upregulated in relapsing-remitting MS, and investigated its transcript and protein levels in blood cells from PP-MS and healthy individuals. We demonstrated transcriptional downregulation of CD161 in PP-MS and described concomitant mRNA reduction for RORgt, CCR6, CXCR6, KLRK1/NKG2D and many other markers typical of mucosa associated invariant T (MAIT) cells. Targeted multiparametric flow cytometry on fresh blood cells from an independent cohort of case-control subjects confirmed the selective loss of circulating CD8 CD161high T cells, which consist mainly of MAIT cells, and not of CD8 CD161int T cells in PP-MS. These data demonstrate alterations in a specific circulating immune cell subset in MS patients with progressive onset.https://www.frontiersin.org/article/10.3389/fimmu.2019.01922/fullCD161CD8bloodprogressive multiple sclerosisMAIT cells
spellingShingle Massimo Acquaviva
Claudia Bassani
Nicole Sarno
Gloria Dalla Costa
Marzia Romeo
Francesca Sangalli
Bruno Colombo
Lucia Moiola
Vittorio Martinelli
Giancarlo Comi
Cinthia Farina
Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
Frontiers in Immunology
CD161
CD8
blood
progressive multiple sclerosis
MAIT cells
title Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
title_full Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
title_fullStr Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
title_full_unstemmed Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
title_short Loss of Circulating CD8+ CD161high T Cells in Primary Progressive Multiple Sclerosis
title_sort loss of circulating cd8 cd161high t cells in primary progressive multiple sclerosis
topic CD161
CD8
blood
progressive multiple sclerosis
MAIT cells
url https://www.frontiersin.org/article/10.3389/fimmu.2019.01922/full
work_keys_str_mv AT massimoacquaviva lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT claudiabassani lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT nicolesarno lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT gloriadallacosta lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT marziaromeo lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT francescasangalli lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT brunocolombo lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT luciamoiola lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT vittoriomartinelli lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT giancarlocomi lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis
AT cinthiafarina lossofcirculatingcd8cd161hightcellsinprimaryprogressivemultiplesclerosis